News for 'drug discovery'

Rhea procured drugs for Sushant through her brother: NCB

Rhea procured drugs for Sushant through her brother: NCB

Rediff.com25 Sep 2020

Rajput's manager Samuel Miranda and cook Dipesh Sawant used to collect the contraband and make `joints' (marijuana cigarettes) for the deceased actor, a NCB officer claimed.

30 groups in India trying to develop COVID-19 vaccine: PSA

30 groups in India trying to develop COVID-19 vaccine: PSA

Rediff.com28 May 2020

Without naming the entity, he said some players are at a pre-clinical stage and may reach the clinical stage by October. Responding to a question on absence of a vaccine currently and the prospects in the next few months as the lockdown eases, VijayRaghvan emphasised on aggressive rapid testing and tracking.

Dr Reddy's to ramp up spending on R&D

Dr Reddy's to ramp up spending on R&D

Rediff.com16 Nov 2007

Dr Reddy's Laboratories Limited aims to increase the R&D spend on its three major research programmes, including the reverse cholesterol transport area, in a bid to come out with pathbreaking molecules in the next 7-10 years.

Ranbaxy revamping for better focus

Ranbaxy revamping for better focus

Rediff.com11 Mar 2005

Ranbaxy Laboratories has decided to separate the two areas of research and development - drug discovery and generics/NDDS/drug development - to achieve increased focus and rigour for success.

Pharma industry's most wanted men

Pharma industry's most wanted men

Rediff.com29 Apr 2004

S K Brahmachari is the new CSIR chief

S K Brahmachari is the new CSIR chief

Rediff.com13 Nov 2007

Eleven months after RA Mashelkar retired from the leadership of India's apex research body, Council of Scientific and Industrial Research (CSIR), the government on Monday appointed Samir K Brahmachari, director, Institute of Genomics & Integrative Biology (IGIB), New Delhi, as the new chief. Brahmachari will also head the Department of Scientific and Industrial Research (DSIR) as secretary.

IT cos focus on healthcare, pharma

IT cos focus on healthcare, pharma

Rediff.com25 Oct 2007

Indian IT service providers are increasing their exposure in the healthcare and pharma segments. Multi-million dollar deals in this space by IT firms over the past three-four months only buttress this trend. Healthcare outsourcing has moved away from just undertaking medical transcription and business process outsourcing (BPO) work to core functions such as drug discovery, testing, research and development.

'Ranbaxy will always be run independently'

'Ranbaxy will always be run independently'

Rediff.com12 Sep 2008

"It will be the team I choose to have with the approval of the board. It is really our call on how to run the business. Certainly, the growth will be higher and so will be the size and scale of the investments. You will see a lot more aggression in terms of leveraging opportunities for the next few years," says Ranbaxy CEO Malvinder Mohan Singh.

Tatas' tie-up with Advinus intact

Tatas' tie-up with Advinus intact

Rediff.com4 May 2007

The Tatas will continue its association with Advinus Therapeutics, the drug discovery start-up company based in Bangalore, and is committed to further invest in the company, said R Gopalakrishnan, chairman of Advinus and executive director, Tata Sons

Ranbaxy R&D unit hive off okayed

Ranbaxy R&D unit hive off okayed

Rediff.com19 Feb 2008

Ranbaxy board has approved the hive off of its R&D unit, with an 1:4 share swap ratio.

US pharma plans $500 mn R&D unit

US pharma plans $500 mn R&D unit

Rediff.com7 Oct 2006

Creative Choice Group plans to create a world-class research centre that will leverage the lower costs in India.

TCS ties up with Israel's BioStrx

TCS ties up with Israel's BioStrx

Rediff.com5 Nov 2004

12 tips to keep your company growing

12 tips to keep your company growing

Rediff.com9 May 2007

You just graduated from tiny to small. Great--now learn how to grow all over again.

HCL Tech plans sciences offering

HCL Tech plans sciences offering

Rediff.com4 May 2005

'No question of bringing in an investor right now'

'No question of bringing in an investor right now'

Rediff.com24 Aug 2024

'We have got enough internal accruals, and we are able to do acquisitions on our own.'

Suven ties up with Eli Lilly

Suven ties up with Eli Lilly

Rediff.com29 Aug 2006

Suven Life Sciences Ltd has signed an agreement with US-based pharmaceutical firm Eli Lilly and Company to carryout pre-clinical research for central nervous system disorder.

Wonder drug for chronic constipation

Wonder drug for chronic constipation

Rediff.com23 Nov 2006

Scientists at the Humboldt University, Berlin, have revealed that a new drug has been found extremely effective in treating nearly all symptoms associated with chronic constipation.

Glaxo keen on more tie-ups

Glaxo keen on more tie-ups

Rediff.com5 Nov 2004

Following its tie-up with Ranbaxy, pharma major GlaxoSmithKline said on Friday it was open to partnership with other Indian companies in the field of drug discovery and development, but it must be allowed to import molecules for research.

The secret behind Glenmark's success

The secret behind Glenmark's success

Rediff.com14 Jun 2006

Covid-19 could be the boost Indian pharma cos need

Covid-19 could be the boost Indian pharma cos need

Rediff.com20 Sep 2020

The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and government researchers are also researching new drug candidates and potential vaccines, says Prosenjit Datta.

Meet the woman behind India's 1st COVID-19 testing kit

Meet the woman behind India's 1st COVID-19 testing kit

Rediff.com30 Mar 2020

Minal Dakhave Bhosale raced against time and delivered the kit, which will deliver the result in 2.5 hours, just a day before giving birth to a baby girl.

Indian-American teen wins $25K for work on potential COVID-19 treatment

Indian-American teen wins $25K for work on potential COVID-19 treatment

Rediff.com19 Oct 2020

Chebrolu said she was inspired to find potential cures to viruses after learning about the 1918 flu pandemic and finding out how many people die every year in the US despite annual vaccinations and anti-influenza drugs on the market.

How India Can Rival China As Production Platform

How India Can Rival China As Production Platform

Rediff.com28 Jul 2023

We have the workforce, now we need to ensure that we take full advantage of game-changing technologies and geopolitical openings, suggests Jayant Sinha, chairman, Parliament's Standing Committee on Finance.

Athletics reels as drug crisis deepens

Athletics reels as drug crisis deepens

Rediff.com23 Oct 2003

The Olympic Games' central sport is tarnished and discredited even as officials have scrambled to defend its credibility.\n\n

Pfizer set to buy Allergan for more than $150 bn

Pfizer set to buy Allergan for more than $150 bn

Rediff.com23 Nov 2015

The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.

What Makes Malayalam Cinema So Distinctive?

What Makes Malayalam Cinema So Distinctive?

Rediff.com11 Apr 2024

The reasons are too private to be discussed at a round table, listed out during a seminar, or uncovered in an academic course. A proud but insomniac connoisseur murmuring in his sleep may do a better job of explaining the phenomenon than an expert on a podium. Sreehari Nair airs his thoughts.

Lupin to buy 21 products of Japan's Shionogi for Rs 1,000 cr

Lupin to buy 21 products of Japan's Shionogi for Rs 1,000 cr

Rediff.com2 Aug 2016

This acquisition marks Lupin's foray into the Japanese branded market in-line with aspirations to build business globally.

'India can locally produce H1N1 drug'

'India can locally produce H1N1 drug'

Rediff.com17 Aug 2009

The H1N1 virus is all that we get to talk or read about now days. While the government continues to move pillar and post to ensure that this problem is brought under control, it also faces another problem -- the shortage of swine flu drug Tamiflu -- thanks to which the problem has risen to such an extent.

'We are looking at flying an Indian into space'

'We are looking at flying an Indian into space'

Rediff.com8 Dec 2023

'It's vital that over the next 10 years, that India, the US and the Artemis Accords family of nations come together to ensure that we not only return humanity to the moon, but that we build the technology that will allow us stay there permanently.' 'And then go on to Mars.'

David vs Goliath: How Wockhardt plans to beat global challenge

David vs Goliath: How Wockhardt plans to beat global challenge

Rediff.com22 Jan 2018

Only 11 antibiotics in clinical trials have received qualified infectious disease product status from the US FDA, of which five are Wockhardt's drugs.

Dengue drug can give Sanofi $1-bn India biz

Dengue drug can give Sanofi $1-bn India biz

Rediff.com10 Nov 2014

The Paris-based global drug giant announced last week that it would have the vaccine available by the first half of next year.

Ramdev's Patanjali claims to have COVID-19 medicine; Govt frowns

Ramdev's Patanjali claims to have COVID-19 medicine; Govt frowns

Rediff.com23 Jun 2020

While Ramdev claimed that Ayurved-based 'Coronil and Swasari' medicine have shown 100 per cent favourable results during clinical trials on COVID-19 infected patients except those on a life support system, the Ayush Ministry sought from the company detailed report on composition, testing and other data of the drugs.

Fine films, fabulous discoveries at MAMI

Fine films, fabulous discoveries at MAMI

Rediff.com19 Oct 2017

The movies that impressed, puzzled and stunned Sukanya Verma at MAMI this year.

'After Vodafone success we will invest more in analytics'

'After Vodafone success we will invest more in analytics'

Rediff.com11 Apr 2014

Piramal Enterprises has about Rs 10,000 crore (Rs 100 billion) cash on its books.